Cargando…
The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes
Adjuvant CIA09, composed of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-based cationic liposomes and the toll-like receptor 4 agonist de-O-acylated lipooligosaccharide (dLOS), has been shown to enhance antibody and cellular immune responses to varicella-zoster virus (VZV) glycoprotein E (gE), r...
Autores principales: | Wui, Seo Ri, Ko, Ara, Ryu, Ji In, Sim, Eojin, Lim, Soo Jeong, Park, Shin Ae, Kim, Kwang Sung, Kim, Ha, Youn, Hyewon, Lee, Na Gyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001429/ https://www.ncbi.nlm.nih.gov/pubmed/33804176 http://dx.doi.org/10.3390/pharmaceutics13030390 |
Ejemplares similares
-
Culture media optimization for Chinese hamster ovary cell growth and expression of recombinant varicella-zoster virus glycoprotein E
por: Kim, Kwang Sung, et al.
Publicado: (2021) -
Processing of virus-specific glycoproteins of varicella zoster virus
por: Namazue, Junko, et al.
Publicado: (1985) -
Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
por: Milicic, Anita, et al.
Publicado: (2012) -
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013) -
Evaluation of glycoprotein E subunit and live attenuated varicella‐zoster virus vaccines formulated with a single‐strand RNA‐based adjuvant
por: Lee, Su Jeen, et al.
Publicado: (2020)